investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML

Michele S Redell

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Roland B Walter

Prediction of Treatment-Related Mortality and Therapeutic Resistance in AML

Leukaemia

Hematology and hematologic malignancies

Effie W Petersdorf

Hematopoietic Stem Cell and Cord Blood Transplantation

Leukaemia

Hematology and hematologic malignancies

Thomas J Kipps

Chronic Lymphocytic Leukemia Research Consortium

Leukaemia

Hematology and hematologic malignancies

Susan L Slager

Genetic Epidemiology Of Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

James L M Ferrara

Cellular and Molecular Studies of Bone Marrow Transplant

Leukaemia

Hematology and hematologic malignancies

David A Fruman

TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance

Leukaemia

Hematology and hematologic malignancies

Catherine Ju-Ying Wu

Defining the Impact of Clonal Evolution on Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

Ronald Hoffman

Myeloproliferative Disorders (MPD) Research Consortium

Leukaemia

Hematology and hematologic malignancies

Marina Y Konopleva

Hypoxia-Selective Kinase Inhibitors for Leukemia Therapy

Leukaemia

Hematology and hematologic malignancies